Surrey M. Walton
Professor, College of Pharmacy-Pharmacy Systems Outcomes and Policy
Assistant Director, Center for Pharmaco Epidemiology and Pharmacoeconomic Research
Core Faculty Member, Center for Pharmacoeconomic Research
Contact
Address:
833 S Wood St. (M/C 871) Rm 264, Chicago, IL
Email:
Related Sites:
About Heading link
Overview:
Surrey Walton is a Professor in the Department of Pharmacy Systems Outcomes and Policy and Assistant Director in the Center for Pharmacoepidemiology and Pharmacoeconomic Research. Prior to arriving at UIC, Dr. Walton received his Ph.D. in Economics from the University of Chicago in 1997, where he specialized in labor and health economics.
Research Interests:
Areas of interest include economic evaluation of health care services and policy, decision analytic modeling, cost and outcomes assessments, and studies of the pharmacy workforce.
Teaching Statement:
Coordinate and teach Pharm D and graduate level courses in the economic evaluation of health care services and have served on numerous graduate thesis committees for PSOP, and the school of public health.
Teaching and Supervision Heading link
Ph.D. Thesis Research (PSOP 599), 1/8/2024 – 4/26/2024
Ph.D. Thesis Research (PSOP 599), 8/21/2023 – 12/1/2023
Ph.D. Thesis Research (PSOP 599), 1/9/2023 – 4/28/2023
Independent Study (PSOP 596), 1/9/2023 – 4/28/2023
Pharmacoeconomics and Payment (PHAR 565), 8/22/2022 – 12/2/2022
Pharmacoeconomics and Payment (PHAR 565), 8/22/2022 – 12/2/2022
Ph.D. Thesis Research (PSOP 599), 8/22/2022 – 12/2/2022
Independent Study (PSOP 596), 8/22/2022 – 12/2/2022
Econmc Eval of Hlthcr Interven (PSOP 573), 8/22/2022 – 12/2/2022
Selected Grants
CTA: ZAIMARA: Zambian Informed Motivated Aware and Responsible Adolescents and Adults, Centre for Infectious Disease Research in Zambia., 9/12/2023 - 8/31/2024, Obligated Amount: $305484; Anticipated Amount: $305484
Mi QUIT CARE (Mile Square QUIT Community-Access-Referral-Expansion), National Institutes of Health (National Heart, Lung, and Blood Institute)., 9/1/2023 - 8/31/2027, Obligated Amount: $1185763; Anticipated Amount: $4684046
UIC subaward - Primary Care Detection of Cognitive Impairment Leveraging Health and Consumer Technologies in Underserved Communities: The MyCog Trial, Northwestern University., 10/1/2022 - 8/31/2027, Obligated Amount: $61801; Anticipated Amount: $161621
Communication Bridge: Optimizing an evidence -based intervention for individuals with primary progressive aphasia, Northwestern University., 9/30/2022 - 8/31/2023, Obligated Amount: $19410; Anticipated Amount: $19410
Walton IDPH Project - Work Order Number: 38100001K, Illinois Department of Public Health., 8/1/2022 - 7/31/2024, Obligated Amount: $529203; Anticipated Amount: $529203
2022 - 2023 Institute for Clinical and Economic Review Consulting Agreement, Institute for Clinical and Economic Review., 1/1/2022 - 12/30/2025, Obligated Amount: $520000; Anticipated Amount: $520000
CTA: Technology-based Training Tool for an Empirically-Supported Group-Based HIV and STI Prevention Intervention for Juvenile Offenders (PHAT Life), Oregon Research Behavioral Intervention Strategies., 9/18/2021 - 5/31/2024, Obligated Amount: $724103; Anticipated Amount: $724103
AbbVie Fellowship 2021-2023 - Surrey Walton and Monika Mandava, AbbVie, Inc.., 5/17/2021 - 5/16/2023, Obligated Amount: $199383; Anticipated Amount: $199383
Multilevel Comprehensive HIV Prevention for South African Adolescent Girls and Young Women, National Institutes of Health (Eunice Kennedy Shriver National Institute of Child Health and Human Development)., 9/4/2020 - 8/31/2024, Obligated Amount: $2649754; Anticipated Amount: $2649754
Selected Publications
Walton, Surrey M, Mayorga, Wilson, Narváez, Angela Rodríguez, Chavez, Maria Alejandra, Guesguán, Natalia Cortés, Durango, Luis, Parada, Ludy Alexandra. (2023). Quantitative revenue estimates and qualitative assessments of innovative fundraising sources for treating rare diseases in Colombia. Journal of Market Access & Health Policy, 11, (1), 2211868. doi:10.1080/20016689.2023.2211868.
Madrid, Katya Cruz, Berbaum, Michael, Walton, Surrey, Zanoni, Joseph, Marquez, David, Muramatsu, Naoko. (2023). PRO-HOME: AN IMPLEMENTATION SCIENCE FRAMEWORK FOR MULTILEVEL BARRIERS AND FACILITATORS IN LTSS. Innovation in Aging, 7, (Supplement_1), 550-550. doi:10.1093/geroni/igad104.1804.
Hatoum, Hind T, Arcona, Steve, Mao, Jianbin, Walton, Surrey. (2023). Real‐world antiseizure medication treatment outcomes in drug‐resistant focal epilepsy patients. Epilepsia Open, 8, (4), 1556-1565. doi:10.1002/epi4.12845.
Jiang, Ruixuan, Pullenayegum, Eleanor, Shaw, James W, Mühlbacher, Axel, Lee, Todd A, Walton, Surrey, Kohlmann, Thomas, Norman, Richard, Pickard, A Simon. (2023). Comparison of Preferences and Data Quality between Discrete Choice Experiments Conducted in Online and Face-to-Face Respondents. Medical Decision Making, 43, (6), 667-679. doi:10.1177/0272989×231171912.
Sarker, J, Moradi, A, Whittington, M, Tice, JA, Herce-Hagiwara, B, Fahim, SM, Chu, J, Agboola, FO, Pearson, S, Rind, DM, Walton, S. (2023). EE555 Cost-Effectiveness of Etranacogene Dezaparvovec for the Treatment of Hemophilia B. Value in Health, 26, (6), s160-s161. doi:10.1016/j.jval.2023.03.2533.
Crane, Melissa M, Walton, Surrey M, Suzuki, Sumihiro, Appelhans, Bradley M. (2023). Quantifying weight loss program preferences of men working in trade and labor occupations: A discrete choice experiment. Obesity Science & Practice, 9, (3), 243-252. doi:10.1002/osp4.642.
Tice, Jeffrey A, Walton, Surrey M, Sarker, Jyotirmoy, Moradi, Ashton, Chu, Janet N, Herce-Hagiwara, Belen, Fahim, Shahariar Mohammed, Agboola, Foluso, Rind, David, Pearson, Steven D. (2023). The effectiveness and value of gene therapy for hemophilia: A Summary from the Institute for Clinical and Economic Review’s California Technology Assessment Forum. Journal of Managed Care & Specialty Pharmacy, 29, (5), 10.18553/jmcp.2023.29.5.576. doi:10.18553/jmcp.2023.29.5.576.
Sarker, J, Joshi, M, Wasfy, JH, Beinfeld, M, Nhan, E, Whittington, M, Pearson, SD, Rind, DM, Walton, SM. (2022). EE457 Long-Term Cost Effectiveness of Mavacamten for Treatment of Hypertrophic Obstructive Cardiomyopathy (HOCM). Value in Health, 25, (7), s424. doi:10.1016/j.jval.2022.04.705.
Beinfeld, Molly, Wasfy, Jason H, Walton, Surrey, Sarker, Jyotirmoy, Nhan, Emily, Rind, David M, Pearson, Steven D. (2022). Mavacamten for hypertrophic cardiomyopathy: effectiveness and value. Journal of Managed Care & Specialty Pharmacy, 28, (3), 10.18553/jmcp.2022.28.3.369. doi:10.18553/jmcp.2022.28.3.369.
Education
Degrees:
Ph.D., University of Chicago, United States, 1997
M.A., University of Chicago, United States, 1992
B.S., University of California Los Angeles, United States, 1991
Selected Presentations
Jiang, Ruixuan, Kohlmann, Thomas, Lee, Todd A, Mühlbacher, Axel, Shaw, James, Walton, Surrey, Pickard, A Simon. (2021 February 01). Increasing respondent engagement in composite time trade-off tasks by imposing three minimum trade-offs to improve data quality. doi:10.1007/s10198-020-01224-6.
Martin, Molly, Rosales, G, Roy, A, Mosnaim, G, Weinstein, S, Walton, S, Bisarini, R. (2019 May 20). Implementation Lessons Regarding Integrated Community Education for Children with Asthma. Rapid Abstract Poster Discussion Session presentation at the American Thoracic Conference 2019. Dallas, USA.